Skip to content
PIL Logo

Dysport 300 units

Last Updated on eMC 19-Jul-2017 View document  | Ipsen Ltd Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 19-Jul-2017 and displayed until Current

Reasons for adding or updating:

  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
  • Change to section 3 - how to take/use
  • Change to section 1 - what the product is used for

Updated on 01-Mar-2017 and displayed until 19-Jul-2017

Reasons for adding or updating:

  • Change to section 1 - what the product is
  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - use in children/adolescents
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 3 - how to take/use
  • Change to section 4 - possible side effects
  • Change to section 6 - what the product contains
  • Change to section 6 - what the product looks like and pack contents
  • Change to section 6 - date of revision
  • Correction of spelling/typing errors

Updated on 11-Jan-2017 and displayed until 01-Mar-2017

Reasons for adding or updating:

  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
  • Correction of spelling/typing errors

Updated on 08-Dec-2016 and displayed until 11-Jan-2017

Reasons for adding or updating:

  • Change to section 1 - what the product is used for
  • Change to section 3 - how to take/use
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
  • Change to name of medicinal product

Updated on 24-Jun-2016 and displayed until 08-Dec-2016

Reasons for adding or updating:

  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision

Updated on 04-Feb-2016 and displayed until 24-Jun-2016

Reasons for adding or updating:

  • Change to section 1 - what the product is
  • Change to section 1 - what the product is used for
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - excipient warnings
  • Change to section 3 - dose and frequency
  • Change to section 3 - how to take/use
  • Change to section 4 - possible side effects
  • Change to section 6 - what the product looks like and pack contents
  • Change to section 6 - date of revision

Updated on 16-Sep-2015 and displayed until 04-Feb-2016

Reasons for adding or updating:

  • Change to section 4 - how to report a side effect
  • Change to section 5 - how to store
  • Change to section 6 - date of revision

Updated on 26-Jun-2012 and displayed until 16-Sep-2015

Reasons for adding or updating:

  • Change/addition of instructions for reconstitution and/ or administration
  • Change to date of revision
  • Change to side-effects

Updated on 31-May-2011 and displayed until 26-Jun-2012

Reasons for adding or updating:

  • Change to date of revision
  • Change to dosage and administration

Updated on 15-Feb-2011 and displayed until 31-May-2011

Reasons for adding or updating:

  • New PIL for new product

Company contact details

Ipsen Ltd

Company image
Address

190 Bath Road, Slough, Berkshire, SL1 3XE

Fax

+44 (0)1753 627 778

Medical Information e-mail
Telephone

+44 (0)1753 627 777

Medical Information Direct Line

+44 (0)1753 627 777

Customer Care direct line

+44 (0)1753 627 627

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

clostridium botulinum type a toxin-haemagglutinin complex

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue